These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6716260)

  • 1. Hepatic tissue binding and the oral first-pass effect.
    Wedlund PJ; Wilkinson GR
    J Pharm Sci; 1984 Mar; 73(3):422-5. PubMed ID: 6716260
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.
    Perucca E; Richens A
    Br J Clin Pharmacol; 1979 Jul; 8(1):21-31. PubMed ID: 552293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
    Huet PM; Lelorier J
    Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-pass clearance of lidocaine in healthy volunteers and epileptic patients: influence of effective liver volume.
    Colburn WA
    J Pharm Sci; 1981 Aug; 70(8):969-71. PubMed ID: 7310681
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of food on lidocaine kinetics: mechanism of food-related alteration in high intrinsic clearance drug elimination.
    Elvin AT; Cole AF; Pieper JA; Rolbin SH; Lalka D
    Clin Pharmacol Ther; 1981 Oct; 30(4):455-60. PubMed ID: 7285479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral absorption and disposition kinetics of lidocaine hydrochloride in dogs.
    Boyes RN; Adams HJ; Duce BR
    J Pharmacol Exp Ther; 1970 Jul; 174(1):1-8. PubMed ID: 5424701
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. I. Effects of continuous infusion.
    Tam YK; Yau M; Berzins R; Montgomery PR; Gray M
    Drug Metab Dispos; 1987; 15(1):12-6. PubMed ID: 2881747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. III. Evaluation of liver models for time-dependent behavior.
    Gray MR; Saville BA; Tam YK
    Drug Metab Dispos; 1987; 15(1):22-6. PubMed ID: 2881754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of portacaval shunt on the disposition of drugs with and without first-pass effect.
    Gugler R; Lain P; Azarnoff DL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):416-23. PubMed ID: 1195128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic and renal clearances of lidocaine in conscious and anesthetized sheep.
    Mather LE; Runciman WB; Carapetis RJ; Ilsley AH; Upton RN
    Anesth Analg; 1986 Sep; 65(9):943-9. PubMed ID: 3740492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cimetidine-induced decrease in lidocaine metabolism.
    Bauer LA; Edwards WA; Randolph FP; Blouin RA
    Am Heart J; 1984 Aug; 108(2):413-5. PubMed ID: 6464978
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation.
    Pang KS; Rowland M
    J Pharmacokinet Biopharm; 1977 Dec; 5(6):655-80. PubMed ID: 599412
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic clearance of lidocaine during N2O anesthesia in dogs.
    Burney RG; DiFazio CA
    Anesth Analg; 1976; 55(3):322-5. PubMed ID: 945010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age on gastrointestinal and hepatic first-pass effects of levodopa in rats.
    Iwamoto K; Watanabe J; Yamada M; Atsumi F; Matsushita T
    J Pharm Pharmacol; 1987 Jun; 39(6):421-5. PubMed ID: 2886598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-pass elimination. Basic concepts and clinical consequences.
    Pond SM; Tozer TN
    Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.
    Ahmad AB; Bennett PN; Rowland M
    J Pharm Pharmacol; 1983 Apr; 35(4):219-24. PubMed ID: 6133930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of first-pass effect on availability of drugs on oral administration.
    Gibaldi M; Boyes RN; Feldman S
    J Pharm Sci; 1971 Sep; 60(9):1338-40. PubMed ID: 5567579
    [No Abstract]   [Full Text] [Related]  

  • 20. Temporary replacements for oral epilepsy treatments.
    Sisodiya SM
    Pract Neurol; 2017 Jan; 17(1):4-5. PubMed ID: 28073924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.